Photo by nci from unsplash
Recently, the 8th edition of the American Joint Committee on Cancer (AJCC) tumor–node–metastasis (TNM) staging system for resected pancreatic ductal adenocarcinoma (PDAC) was introduced into clinical practice. Although it showed… Click to show full abstract
Recently, the 8th edition of the American Joint Committee on Cancer (AJCC) tumor–node–metastasis (TNM) staging system for resected pancreatic ductal adenocarcinoma (PDAC) was introduced into clinical practice. Although it showed improved discriminative power as compared with the 7th edition, it has been validated in high-volume pancreatic centers only. Consequently, its general applicability could be questioned. In addition, four recent studies have proposed modifications of the 8th edition. These modifications demonstrated a further increase in prognostic accuracy but lack external validation.
Journal Title: Annals of Surgical Oncology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!